"The growth of the genome editing market is primarily attributed to the rise
in the production of genetically modified crops and rising prevalence of the
genetic diseases," according to the latest Genome Editing Market Growth
Analysis Report. Overall, the market is expected to have a compound annual
growth rate (CAGR) of 17.2% from 2018 to 2025. Despite rigid biosafety
regulations on genome editing in the region, the emergence of markets
centered on precision and regenerative medicines provides more growth
opportunities for the North American genome editing market in the next
couple of years.



The CRISPR segment, which dominated the genome editing market in 2017 with a
share of 53.6%, is still expected to take up a significant portion of the
market in 2025. Based on application, the cell line engineering segment is
likewise foreseen to propel at a CAGR of 18.0%. Similarly, the genetic
engineering segment will likely see a a substantial increase due to
extensive researches being done on its subsegments, particularly on animal
and plant genetic engineering. With the advent of CRISPR, the biotechnology
and pharmaceutical companies segment is also anticipated to dominate the
market in 2025 as companies benefit from drug discoveries and enhanced
research and development.



[tradingexaminer24.com]
is-by-manufacturers-regions-type-and-application-forecast-analysis/